Janus Henderson Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $117M | Sell |
|
|||||
|
2025
Q2 | $89.3M | Sell |
|
|||||
|
2025
Q1 | $90.7M | Buy |
|
|||||
|
2024
Q4 | $68.3M | Buy |
|
|||||
|
2024
Q3 | $31.3M | Buy |
|
|||||
|
2024
Q2 | $24.4M | Sell |
|
|||||
|
2024
Q1 | $26.9M | Sell |
|
|||||
|
2023
Q4 | $28.6M | Sell |
|
|||||
|
2023
Q3 | $24.4M | Sell |
|
|||||
|
2023
Q2 | $17.8M | Sell |
|
|||||
|
2023
Q1 | $19.6M | Sell |
|
|||||
|
2022
Q4 | $36.1M | Sell |
|
|||||
|
2022
Q3 | $76.5M | Buy |
|
|||||
|
2022
Q2 | $8.63M | Sell |
|
|||||
|
2022
Q1 | $34M | Sell |
|
|||||
|
2021
Q4 | $31.3M | Sell |
|
|||||
|
2021
Q3 | $41.6M | Sell |
|
|||||
|
2021
Q2 | $76.9M | Sell |
|
|||||
|
2021
Q1 | $87M | Sell |
|
|||||
|
2020
Q4 | $134M | Buy |
|
|||||
|
2020
Q3 | $95.1M | Sell |
|
|||||
|
2020
Q2 | $98.4M | Buy |
|
|||||
|
2020
Q1 | $65.7M | Buy |
|
|||||
|
2019
Q4 | $98.8M | Buy |
|
|||||
|
2019
Q3 | $73.6M | Buy |
|
|||||
|
2019
Q2 | $72.4M | Buy |
|
|||||
|
2019
Q1 | $90M | Buy |
|
|||||
|
2018
Q4 | $87.7M | Buy |
|
|||||
|
2018
Q3 | $89M | Buy |
|
|||||
|
2018
Q2 | $71.6M | Buy |
|
|||||
|
2018
Q1 | $21.8M | Buy |
|
|||||
|
2017
Q4 | $21.9M | Buy |
|